An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)

A Study to Assess the Safety and Efficacy of MK0364 in Obese Patients

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00109148

Enrollment

500

Registered

2005-04-25

Start date

2004-07-31

Completion date

2005-02-28

Last updated

2015-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity and obesity-related medical conditions

Brief summary

The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with obesity (considerably overweight).

Interventions

DRUGMK0364

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

* Patients who are obese (considerably overweight) based on body mass index.

Exclusion criteria

* Patients with serious or unstable current or past medical conditions

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026